Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell.

(SAVA) - Analyzing Cassava Sciences's Short Interest ↗

January 29, 2024

Via Benzinga

3 Biotech Stocks to Sell in January Before They Crash and Burn ↗

January 25, 2024

Cassava Sciences sees its Relative Strength Rating move into the elite 90-plus level.

Cassava Sciences Stock Continues Showing Rising Relative Strength ↗

January 16, 2024

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 15, 2024

Via Benzinga

Portfolio Protection: 7 Risky Stocks to Drop Right Now ↗

January 12, 2024

Ahead of further or unforeseen challenges, if you own any of these seven risky stocks, now's the time to bail.

Playing the blame game does not make for an effective turnaround strategy.

1 Big Red Flag to Fear When a Stock Is Down ↗

October 31, 2023

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher after the company announced MRI data suggested simufilam is not associated with amyloid-

Why Cassava Sciences Stock Surged Today ↗

October 25, 2023

Via Benzinga

New SAVAW Warrants Are Trading After Cassava Sciences’ Distribution ↗

January 05, 2024

Following a distribution, investors in Cassava Sciences and SAVA stock now have some warrants to factor into their models today.

Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders

January 05, 2024

Wall Street analysts foresee up to 316% upside in three fast-paced companies in the new year.

3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street ↗

December 26, 2023

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 21, 2023

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

Via Benzinga

Paychex Reports Downbeat Sales, Joins BlackBerry And Other Big Stocks Moving Lower On Thursday ↗

December 21, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Thursday.

Via Benzinga

Topics Stocks

Why Cassava Sciences Stock Zoomed 21% Higher This Week ↗

December 15, 2023

The company has chosen an offbeat way to keep its investors sweet.

Cassava Sciences sees its Relative Strength Rating reach the 80-plus level.

Cassava Sciences Stock Shows Rising Relative Strength Following 3 Up Days ↗

December 13, 2023

Via Investor's Business Daily

Why Is Cassava Sciences (SAVA) Stock Up 15% Today? ↗

December 12, 2023

Although Cassava Sciences’ issuance of warrants presents risks, the underlying Phase 3 trial support boosted SAVA stock.

Blue Bird Posts Upbeat Results, Joins Oil-Dri Corporation of America, Eagle Bulk Shipping And Other Big Stocks Moving Higher On Tuesday ↗

December 12, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Tuesday.

Via Benzinga

Topics Stocks

Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders

December 12, 2023

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher Monday on continued upward momentum. The stock has gained more than 20% over than last five days. What To Know:

What's Going On With Cassava Sciences Stock? ↗

December 11, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 11, 2023

Via Benzinga

High short interest stocks: this popular trend is re-emerging

December 11, 2023

Renewed optimism has led to higher risk tolerance in stocks, which has brought back a popular trend: Stocks with high short interest are gaining popularity

Via MarketBeat

Topics ETFs

Why Cassava Sciences Stock Soared Today ↗

December 08, 2023

Investors cheered the arrival of a trio of new board members.

Dr. Nicaise, Mr. Gravier and Mr. Anderson have years of experience in drug development, healthcare M&A and working with the U.S. Government

Cassava Sciences Appoints Three New Members to its Board of Directors

December 07, 2023

While most folks should stick on the established road, these stock picks for contrarian investors might tempt the intrepid.

7 High-Risk, High-Reward Stocks for the Extreme Contrarian ↗

November 14, 2023

Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results

November 07, 2023

Cassava Sciences Completes Enrollment for Pivotal Phase 3 Program of Simufilam in Alzheimer’s Disease

November 06, 2023

MRI Data Suggest Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA)

October 25, 2023

There's always a bear market somewhere. Here are seven stocks to sell that investors should definitely unload now.

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 24, 2023

Via Benzinga

7 Stocks That Are Heading for a Train Wreck ↗

October 19, 2023